2024MAY10: Our hosting provider is experiencing intermittent networking issues. We apologize for any inconvenience.

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19.

Cell | 2021

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus is causing a global pandemic, and cases continue to rise. Most infected individuals experience mildly symptomatic coronavirus disease 2019 (COVID-19), but it is unknown whether this can induce persistent immune memory that could contribute to immunity. We performed a longitudinal assessment of individuals recovered from mild COVID-19 to determine whether they develop and sustain multifaceted SARS-CoV-2-specific immunological memory. Recovered individuals developed SARS-CoV-2-specific immunoglobulin (IgG) antibodies, neutralizing plasma, and memory B and memory T cells that persisted for at least 3 months. Our data further reveal that SARS-CoV-2-specific IgG memory B cells increased over time. Additionally, SARS-CoV-2-specific memory lymphocytes exhibited characteristics associated with potent antiviral function: memory T cells secreted cytokines and expanded upon antigen re-encounter, whereas memory B cells expressed receptors capable of neutralizing virus when expressed as monoclonal antibodies. Therefore, mild COVID-19 elicits memory lymphocytes that persist and display functional hallmarks of antiviral immunity.

Pubmed ID: 33296701 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Antibodies used in this publication

Associated grants

  • Agency: NIAID NIH HHS, United States
    Id: R01 AI118803
  • Agency: NIAID NIH HHS, United States
    Id: T32 AI106677
  • Agency: NIH HHS, United States
    Id: S10 OD024979
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK089507
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI127726
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI150178
  • Agency: NCATS NIH HHS, United States
    Id: TL1 TR002318
  • Agency: NIAID NIH HHS, United States
    Id: U01 AI142001
  • Agency: NIAID NIH HHS, United States
    Id: U01 AI151698
  • Agency: NIAID NIH HHS, United States
    Id: U19 AI125378

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


SAV BUV395 100ug (antibody)

RRID:AB_2869553

This unknown targets

View all literature mentions

Goat Anti-Human IgA-HRP (antibody)

RRID:AB_2687526

This unknown targets Human IgA

View all literature mentions

BV605 Rat Anti-Mouse CD138 (antibody)

RRID:AB_2721029

This monoclonal targets CD138

View all literature mentions

CD45R (B220) (antibody)

RRID:AB_2738470

This monoclonal targets CD45R (B220)

View all literature mentions

CD4 (antibody)

RRID:AB_395013

This monoclonal targets CD4

View all literature mentions

APC/Cyanine7 anti-human IFN-gamma (antibody)

RRID:AB_10663412

This monoclonal targets IFN-gamma

View all literature mentions

PE/Cyanine7 anti-human IL-4 (antibody)

RRID:AB_2126746

This monoclonal targets IL-4

View all literature mentions

CD69 (antibody)

RRID:AB_2738770

This monoclonal targets CD69

View all literature mentions

APC/Fire(TM) 750 anti-human TCR gamma/delta (antibody)

RRID:AB_2650627

This monoclonal targets TCR gamma/delta

View all literature mentions

PE anti-human IL-13 (antibody)

RRID:AB_315198

This monoclonal targets IL-13

View all literature mentions

FITC anti-human IL-4 (antibody)

RRID:AB_315125

This monoclonal targets IL-4

View all literature mentions

APC anti-human CD19 (antibody)

RRID:AB_2564128

This monoclonal targets CD19

View all literature mentions

CD185 (CXCR5) (antibody)

RRID:AB_2738871

This monoclonal targets CD185 (CXCR5)

View all literature mentions

CD127 (IL-7 Receptor α) (antibody)

RRID:AB_2738138

This monoclonal targets CD127 (IL-7 Receptor α)

View all literature mentions

GM-CSF (antibody)

RRID:AB_2737899

This monoclonal targets GM-CSF

View all literature mentions

CD3 (antibody)

RRID:AB_2744382

This monoclonal targets CD3

View all literature mentions

APC anti-human HLA-DR (antibody)

RRID:AB_314688

This monoclonal targets HLA-DR

View all literature mentions

APC anti-human CD279 (PD-1) (antibody)

RRID:AB_940475

This monoclonal targets CD279

View all literature mentions

PE/Cyanine7 anti-T-bet (antibody)

RRID:AB_2561760

This monoclonal targets T-bet

View all literature mentions

Blimp-1 (antibody)

RRID:AB_2739147

This monoclonal targets Blimp-1

View all literature mentions

CD183 (antibody)

RRID:AB_10892799

This monoclonal targets CD183 (CXCR3)

View all literature mentions

PE anti-human/mouse Bcl-6 (antibody)

RRID:AB_2562152

This monoclonal targets Bcl-6

View all literature mentions

Hu CD8 BV750 SK1 50ug (antibody)

RRID:AB_2871850

This monoclonal targets CD8

View all literature mentions

CD14 (antibody)

RRID:AB_2740436

This monoclonal targets CD14

View all literature mentions

CD19 (antibody)

RRID:AB_2737970

This monoclonal targets CD19

View all literature mentions

CD196 (CCR6) (antibody)

RRID:AB_2738488

This monoclonal targets CD196 (CCR6)

View all literature mentions

BV510 Mouse Anti-Human CD3 (antibody)

RRID:AB_2732053

This monoclonal targets CD3

View all literature mentions

CD185 (CXCR5) (antibody)

RRID:AB_2737766

This monoclonal targets CD185 (CXCR5)

View all literature mentions

Hu CD45RA BUV737 HI100 100Tst (antibody)

RRID:AB_2870168

This monoclonal targets CD45RA

View all literature mentions

Ki-67 (antibody)

RRID:AB_2738577

This monoclonal targets Ki-67

View all literature mentions

IgG (antibody)

RRID:AB_2738684

This monoclonal targets IgG

View all literature mentions

BV711 Mouse Anti-Human CD16 (antibody)

RRID:AB_2732050

This monoclonal targets CD16

View all literature mentions

CD14 (antibody)

RRID:AB_2744290

This monoclonal targets CD14

View all literature mentions

CD3 (antibody)

RRID:AB_2744392

This monoclonal targets CD3

View all literature mentions

CD19 (antibody)

RRID:AB_395812

This monoclonal targets CD19

View all literature mentions

APC anti-human CD41 (antibody)

RRID:AB_2249385

This monoclonal targets CD41

View all literature mentions

PE/Cyanine7 anti-human CD163 (antibody)

RRID:AB_2562641

This monoclonal targets CD163

View all literature mentions

PE anti-human CD9 (antibody)

RRID:AB_2075892

This monoclonal targets CD9

View all literature mentions

FITC anti-human CD89 (antibody)

RRID:AB_2728341

This monoclonal targets CD89

View all literature mentions

Hu CD56 BUV737 NCAM16.2 25Tst (antibody)

RRID:AB_2860005

This monoclonal targets CD56 (NCAM-1)

View all literature mentions

Hu CD14 BUV615 M5E2 50ug (antibody)

RRID:AB_2875174

This monoclonal targets CD14

View all literature mentions

BUV563 Mouse Anti-Human CD15 (antibody)

RRID:AB_2868406

This monoclonal targets CD15

View all literature mentions

CD16 (FcγRIII) (antibody)

RRID:AB_2744293

This monoclonal targets CD16 (FcγRIII)

View all literature mentions